MoneyWorks4Me

Hikal informs about unaudited financial results

24 Oct 2018 Evaluate

Hikal has informed that the meeting of the Board of Directors of the Company is scheduled on 01/11/2018, to consider and approve unaudited financial results for quarter ended 30th September 2018.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..